Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Aspen has delivered double-digit earnings growth, despite a challenging trading environment characterised by inflationary cost pressures. The pharmaceutical firm has reported a 31% increase in annual headline earnings per share and has hiked its dividend by 24% to R3.26. Business Day TV unpacked the results with Stephen Saad.
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
NEWS LEADER
WATCH: Aspen posts double-digit earnings growth
Business Day TV speaks to Aspen CEO Stephen Saad
Aspen has delivered double-digit earnings growth, despite a challenging trading environment characterised by inflationary cost pressures. The pharmaceutical firm has reported a 31% increase in annual headline earnings per share and has hiked its dividend by 24% to R3.26. Business Day TV unpacked the results with Stephen Saad.
Or listen to full audio
Subscribe for free episodes: iono.fm | Apple Podcasts | Spotify | Pocket Casts | Player.fm
Aspen seals deal with Serum Institute to make vaccines for Africa
Aspen shares gain the most since mid-March as investors cheer results
WATCH: Sun International declares first dividend in six years
WATCH: Master Drilling CEO Danie Pretorius on its record results
WATCH: Massmart CEO Mitchell Slape on Walmart’s buyout offer
WATCH: Brimstone’s operating profit dips as fair value gains on listed investments fall
Companies in this Story
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.